Skip to main content
. 2019 Jul 18;11(7):1004. doi: 10.3390/cancers11071004

Table 3.

Analysis of hypoxia-inducible factor 1-alpha (HIF1a) and von Hippel–Lindau (VHL) mRNA expression in relation to chromosome status and BAP1 (based on the n = 54 lesions with data on HIF1a/VHL and chromosome status from the Leiden data).

Total HIF1a VHL
CATEGORICAL Cases (%) Median p-Value Median p-Value
All patients
Chromosome 3
D3 20 (37) 7.02 0.001 * 8.23 <0.001 *
M3 34 (63) 7.24 7.69
Chromosome 8q
Normal 13 (24) 7.01 0.003 * 8.22 0.001 *
Gain 41 (76) 7.24 7.74
BAP1 IHC
Negative 30 (56) 7.28 <0.001 * 7.71 0.003 *
Positive 24 (54) 7.02 8.17
Sub-group analysis
Within D3 Lesions
D3/BAP1− 3 7.30 0.028 * 8.23 0.921
D3/BAP1+ 17 7.01 8.23
Within M3 Lesions
M3/BAP1− 27 7.25 0.015 * 7.70 0.647
M3/BAP1+ 7 7.10 7.56
Within D3/BAP1+ Lesions
D3/BAP1+/n8q 9 6.98 0.200 8.22 1.000
D3/BAP1+/8qgain 8 7.07 8.32

The p-values were calculated with the Mann–Whitney U test; * indicates significant p-values. Abbreviations: BAP1+, BAP1-positive; BAP1−, BAP1-negative; n8q, normal chromosome 8q; 8qgain, gain of chromosome 8q; D3, disomy 3; M3, monosomy 3; IHC, immunohistochemistry.